Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sandrine Menguy"'
Autor:
Camille Devanlay, Emmanuelle Tavernier-Tardy, Aurélie Bourmaud, Alexander Tuan Falk, Hélène Raberin, Sandrine Menguy, Denis Guyotat, Nicolas Magné, Jérôme Cornillon
Publikováno v:
Biomedical Journal, Vol 38, Iss 3, Pp 235-243 (2015)
Background: Invasive fungal infections (IFIs) remain one of the worrying complications in patients with acute myeloid leukemia (AML) due to their incidence and high level of attributable mortality. In light of these risks, antifungal prophylaxis has
Externí odkaz:
https://doaj.org/article/b8575b82e39e49ab88857fe0fb9f7ca3
Autor:
Agnès Macé, Sandrine Menguy, Lucie Cornet, Caroline Gervaise, Fabien Tinquaut, Fabien Forges, Xavier Simoens, Marion Hugues
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(8)
Introduction The aim of the study was to identify risk factors related to human errors in the preparation of anticancer drugs in order to improve the pharmaceutical process by setting corrective actions. Method Risk factors which could increase the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc70de39b36585a2b234e5f0be77c8d
https://pubmed.ncbi.nlm.nih.gov/33203300
https://pubmed.ncbi.nlm.nih.gov/33203300
Autor:
Agnès Macé, Marion Hugues, Emeline Blanc, Jérôme Guitton, Fabien Tinquaut, Fabien Forges, Wafa Bouleftour, Corinne Macron, Bastien Raymond, Sandrine Menguy, Xavier Simoens
Publikováno v:
International archives of occupational and environmental health. 94(6)
Despite the decreasing of environmental contamination throughout the anticancer drug circuit, the administration of chemotherapies remains at risk of occupational exposure for nurses. Many medical devices aim at securing administration, but none have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0fa68a4b224c06d8e4b2f28275f676e
https://pubmed.ncbi.nlm.nih.gov/33733326
https://pubmed.ncbi.nlm.nih.gov/33733326
Autor:
Nicolas Magné, Camille C. Devanlay, Denis Guyotat, Aurélie Bourmaud, Hélène Raberin, Sandrine Menguy, Emmanuelle Tavernier-Tardy, Alexander T. Falk, Jérôme Cornillon
Publikováno v:
Biomedical Journal, Vol 38, Iss 3, Pp 235-243 (2015)
Background: Invasive fungal infections (IFIs) remain one of the worrying complications in patients with acute myeloid leukemia (AML) due to their incidence and high level of attributable mortality. In light of these risks, antifungal prophylaxis has
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8cdeea5c1f002a6e558962c269f2ad9
http://www.biomedj.org/article.asp?issn=2319-4170
http://www.biomedj.org/article.asp?issn=2319-4170